Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2897517rdf:typepubmed:Citationlld:pubmed
pubmed-article:2897517lifeskim:mentionsumls-concept:C0019196lld:lifeskim
pubmed-article:2897517lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2897517lifeskim:mentionsumls-concept:C0018821lld:lifeskim
pubmed-article:2897517lifeskim:mentionsumls-concept:C0021027lld:lifeskim
pubmed-article:2897517lifeskim:mentionsumls-concept:C0205370lld:lifeskim
pubmed-article:2897517lifeskim:mentionsumls-concept:C1708528lld:lifeskim
pubmed-article:2897517pubmed:issue8597lld:pubmed
pubmed-article:2897517pubmed:dateCreated1988-7-11lld:pubmed
pubmed-article:2897517pubmed:abstractTextTo evaluate the effectiveness of immune serum globulin (ISG) in preventing non-A, non-B hepatitis, 291 heart surgery patients who received blood from voluntary donors were randomly assigned to receive either ISG or no additional protection. ISG was given intramuscularly before and 1 week after transfusion. 98 controls and 100 in the ISG group completed the study. Post-transfusion non-A, non-B hepatitis developed in 11 (11.2%) controls but in only 3 (3.0%) of the ISG group (p = 0.0203). 8 (72.7%) of control group with hepatitis had symptoms, and in 5 (45.4%) the disease became chronic. The disease was self-limiting in all 3 ISG patients affected, and only 1 of them had symptoms. Among those with non-A, non-B hepatitis aminotransferase levels were higher in the controls than in the ISG patients. Incubation periods longer than 8 weeks correlated with a tendency for the disease to become chronic. ISG recipients had shorter as well as more homogeneous incubation periods. ISG could be a safe, low-cost means for preventing post-transfusion non-A, non-B hepatitis which does not call for the discarding of donated blood.lld:pubmed
pubmed-article:2897517pubmed:languageenglld:pubmed
pubmed-article:2897517pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2897517pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2897517pubmed:statusMEDLINElld:pubmed
pubmed-article:2897517pubmed:monthJunlld:pubmed
pubmed-article:2897517pubmed:issn0140-6736lld:pubmed
pubmed-article:2897517pubmed:authorpubmed-author:RiveraFFlld:pubmed
pubmed-article:2897517pubmed:authorpubmed-author:CastroRRlld:pubmed
pubmed-article:2897517pubmed:authorpubmed-author:MuñozJJlld:pubmed
pubmed-article:2897517pubmed:authorpubmed-author:García De...lld:pubmed
pubmed-article:2897517pubmed:authorpubmed-author:LealMMlld:pubmed
pubmed-article:2897517pubmed:authorpubmed-author:Sánchez-Quija...lld:pubmed
pubmed-article:2897517pubmed:authorpubmed-author:PinedaJ AJAlld:pubmed
pubmed-article:2897517pubmed:authorpubmed-author:LissenEElld:pubmed
pubmed-article:2897517pubmed:authorpubmed-author:Díaz-TorresM...lld:pubmed
pubmed-article:2897517pubmed:issnTypePrintlld:pubmed
pubmed-article:2897517pubmed:day4lld:pubmed
pubmed-article:2897517pubmed:volume1lld:pubmed
pubmed-article:2897517pubmed:ownerNLMlld:pubmed
pubmed-article:2897517pubmed:authorsCompleteYlld:pubmed
pubmed-article:2897517pubmed:pagination1245-9lld:pubmed
pubmed-article:2897517pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:meshHeadingpubmed-meshheading:2897517-...lld:pubmed
pubmed-article:2897517pubmed:year1988lld:pubmed
pubmed-article:2897517pubmed:articleTitlePrevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients.lld:pubmed
pubmed-article:2897517pubmed:affiliationDepartment of Internal Medicine, Virgen del Rocío Hospital, Seville, Spain.lld:pubmed
pubmed-article:2897517pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2897517pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2897517pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:2897517pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:2897517pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2897517lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2897517lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2897517lld:pubmed